LeMaitre Vascular Stock Price, News & Analysis (NASDAQ:LMAT)

$35.27 0.00 (0.00 %)
(As of 02/18/2018 12:49 PM ET)
Previous Close$35.27
Today's Range$34.86 - $35.50
52-Week Range$19.82 - $39.88
Volume73,660 shs
Average Volume119,496 shs
Market Capitalization$679.48 million
P/E Ratio45.81
Dividend Yield0.62%
Beta0.53

About LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular logoLeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Receive LMAT News and Ratings via Email

Sign-up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:LMAT
CUSIPN/A
Phone781-221-2266

Debt

Debt-to-Equity RatioN/A
Current Ratio6.25%
Quick Ratio4.50%

Price-To-Earnings

Trailing P/E Ratio45.8057896855803
Forward P/E Ratio41.99
P/E Growth2.71

Sales & Book Value

Annual Sales$89.15 million
Price / Sales7.62
Cash Flow$0.76 per share
Price / Cash46.22
Book Value$4.71 per share
Price / Book7.49

Profitability

Trailing EPS$0.77
Net Income$10.59 million
Net Margins15.81%
Return on Equity16.16%
Return on Assets14.03%

Miscellaneous

Employees397
Outstanding Shares19,260,000

LeMaitre Vascular (NASDAQ:LMAT) Frequently Asked Questions

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular announced a quarterly dividend on Monday, October 30th. Stockholders of record on Wednesday, November 22nd will be paid a dividend of $0.055 per share on Thursday, December 7th. This represents a $0.22 annualized dividend and a dividend yield of 0.62%. The ex-dividend date of this dividend is Tuesday, November 21st. View LeMaitre Vascular's Dividend History.

How will LeMaitre Vascular's stock buyback program work?

LeMaitre Vascular declared that its board has initiated a stock buyback program on Friday, July 28th 2017, which authorizes the company to buyback $7,500,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 1.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's management believes its stock is undervalued.

How were LeMaitre Vascular's earnings last quarter?

LeMaitre Vascular Inc (NASDAQ:LMAT) released its quarterly earnings data on Thursday, October, 26th. The medical instruments supplier reported $0.25 EPS for the quarter, beating the Zacks' consensus estimate of $0.20 by $0.05. The medical instruments supplier earned $24.80 million during the quarter, compared to the consensus estimate of $25.49 million. LeMaitre Vascular had a net margin of 15.81% and a return on equity of 16.16%. The firm's quarterly revenue was up 6.9% compared to the same quarter last year. During the same period last year, the firm posted $0.17 EPS. View LeMaitre Vascular's Earnings History.

Where is LeMaitre Vascular's stock going? Where will LeMaitre Vascular's stock price be in 2018?

6 equities research analysts have issued 12-month target prices for LeMaitre Vascular's stock. Their predictions range from $29.00 to $34.00. On average, they anticipate LeMaitre Vascular's share price to reach $31.50 in the next year. View Analyst Ratings for LeMaitre Vascular.

What are Wall Street analysts saying about LeMaitre Vascular stock?

Here are some recent quotes from research analysts about LeMaitre Vascular stock:

  • 1. According to Zacks Investment Research, "LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. " (1/3/2018)
  • 2. Canaccord Genuity analysts commented, "We view this event as largely priced in, given the previous success in narcolepsy in a Phase II trial and a successful read-out from two Phase III trials in excessive sleepiness (ES) associated with obstructive sleep apnea (OSA). We currently model an 80% probability of approval and risk-adjusted sales of $558.9 million in 2026." (4/27/2017)

Who are some of LeMaitre Vascular's key competitors?

Who are LeMaitre Vascular's key executives?

LeMaitre Vascular's management team includes the folowing people:

  • George W. LeMaitre, Chairman of the Board, Chief Executive Officer (Age 52)
  • David Brian Roberts, President, Director (Age 53)
  • Joseph P. Pellegrino Jr., Chief Financial Officer, Director (Age 52)
  • Trent G. Kamke, Senior Vice President - Operations (Age 46)
  • Cornelia W. LeMaitre, Vice President - Human Resources (Age 79)
  • Lawrence J. Jasinski, Independent Director (Age 59)
  • John J. O'Connor, Independent Director (Age 69)
  • John A. Roush, Independent Director (Age 52)
  • Michael H. Thomas, Independent Director (Age 67)

Who owns LeMaitre Vascular stock?

LeMaitre Vascular's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.76%), Conestoga Capital Advisors LLC (6.89%), AWM Investment Company Inc. (2.62%), Ranger Investment Management L.P. (1.99%), Thomson Horstmann & Bryant Inc. (1.85%) and Allianz Asset Management GmbH (1.81%). Company insiders that own LeMaitre Vascular stock include Cornelia W Lemaitre, David B Roberts, George W Lemaitre, Lawrence J Jasinski, Michael T Wijas, Peter R Gebauer and Trent G Kamke. View Institutional Ownership Trends for LeMaitre Vascular.

Who sold LeMaitre Vascular stock? Who is selling LeMaitre Vascular stock?

LeMaitre Vascular's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Globeflex Capital L P, Cornerstone Capital Management Holdings LLC., Driehaus Capital Management LLC, AWM Investment Company Inc., Martingale Asset Management L P, Acadian Asset Management LLC and Concorde Asset Management LLC. Company insiders that have sold LeMaitre Vascular company stock in the last year include David B Roberts, George W Lemaitre, Lawrence J Jasinski, Michael T Wijas, Peter R Gebauer and Trent G Kamke. View Insider Buying and Selling for LeMaitre Vascular.

Who bought LeMaitre Vascular stock? Who is buying LeMaitre Vascular stock?

LeMaitre Vascular's stock was bought by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Biondo Investment Advisors LLC, BlackRock Inc., Assenagon Asset Management S.A., Thomson Horstmann & Bryant Inc., Allianz Asset Management GmbH, American Century Companies Inc. and Arizona State Retirement System. View Insider Buying and Selling for LeMaitre Vascular.

How do I buy LeMaitre Vascular stock?

Shares of LeMaitre Vascular can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LeMaitre Vascular's stock price today?

One share of LeMaitre Vascular stock can currently be purchased for approximately $35.27.

How big of a company is LeMaitre Vascular?

LeMaitre Vascular has a market capitalization of $679.48 million and generates $89.15 million in revenue each year. The medical instruments supplier earns $10.59 million in net income (profit) each year or $0.77 on an earnings per share basis. LeMaitre Vascular employs 397 workers across the globe.

How can I contact LeMaitre Vascular?

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at 781-221-2266.


MarketBeat Community Rating for LeMaitre Vascular (LMAT)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  257 (Vote Outperform)
Underperform Votes:  162 (Vote Underperform)
Total Votes:  419
MarketBeat's community ratings are surveys of what our community members think about LeMaitre Vascular and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

LeMaitre Vascular (NASDAQ:LMAT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.172.172.172.43
Ratings Breakdown: 0 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $31.50$31.50$31.50$28.60
Price Target Upside: 0.77% upside0.77% upside0.77% upside15.73% downside

LeMaitre Vascular (NASDAQ:LMAT) Consensus Price Target History

Price Target History for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/29/2017Stifel NicolausReiterated RatingBuyN/AView Rating Details
10/27/2017Canaccord GenuityLower Price TargetHold$30.00 -> $29.00N/AView Rating Details
10/27/2017BenchmarkDowngradeBuy -> HoldN/AView Rating Details
10/27/2017First AnalysisDowngradeOverweight -> Equal Weight$34.00N/AView Rating Details
6/6/2017Craig HallumInitiated CoverageHold$31.00LowView Rating Details
2/22/2017Barrington ResearchDowngradeOutperform -> Market PerformN/AView Rating Details
9/22/2016SidotiDowngradeBuy -> Neutral$23.00N/AView Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$17.50 -> $20.00N/AView Rating Details
5/3/2016Roth CapitalBoost Price TargetBuy$18.00 -> $18.50N/AView Rating Details
(Data available from 2/18/2016 forward)

Earnings

LeMaitre Vascular (NASDAQ:LMAT) Earnings History and Estimates Chart

Earnings by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ LMAT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2017Q3 2017$0.20$0.25$25.49 million$24.80 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.17$0.23$25.42 million$25.80 millionViewN/AView Earnings Details
5/4/2017Q1 2017$0.13$0.16$23.48 million$24.10 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.13$0.16$23.50 million$24.14 millionViewN/AView Earnings Details
2/21/2017Q4 2016$0.15$0.13$23.70 million$23.30 millionViewListenView Earnings Details
10/26/2016Q3$0.15$0.17$22.20 million$19.00 millionViewListenView Earnings Details
7/27/2016Q2$0.11$0.14$21.59 million$22.40 millionViewListenView Earnings Details
5/2/2016Q1$0.10$0.11$20.22 million$20.26 millionViewListenView Earnings Details
2/24/2016Q415$0.09$0.13$20.10 million$20.50 millionViewListenView Earnings Details
10/27/2015Q3$0.08$0.11$18.78 million$19.03 millionViewListenView Earnings Details
7/28/2015Q2$0.07$0.10$18.90 million$19.90 millionViewListenView Earnings Details
4/28/2015Q115$0.05$0.08$17.76 million$18.90 millionViewListenView Earnings Details
2/25/2015Q314$0.07$0.11$18.90 million$18.70 millionViewListenView Earnings Details
10/28/2014Q3$0.06$0.05$17.09 million$17.50 millionViewListenView Earnings Details
7/29/2014Q2 2014$0.05$0.09$17.57 million$18.16 millionViewN/AView Earnings Details
4/29/2014Q1 2014$0.02$0.02$16.99 million$16.75 millionViewN/AView Earnings Details
2/25/2014Q4$0.05$0.05$16.45 million$17.92 millionViewListenView Earnings Details
10/29/2013Q313$0.04$0.05$15.22 million$15.30 millionViewListenView Earnings Details
7/30/2013Q2 2013$0.04$0.06$15.42 million$15.95 millionViewN/AView Earnings Details
4/30/2013Q1 2013($0.01)$0.05$15.00 million$15.38 millionViewN/AView Earnings Details
2/26/2013Q4 2012$0.06$0.03ViewN/AView Earnings Details
10/30/2012Q3 2012$0.04$0.04ViewN/AView Earnings Details
7/31/2012Q2 2012$0.04$0.05ViewN/AView Earnings Details
5/2/2012Q1 2012$0.04$0.02ViewN/AView Earnings Details
2/27/2012Q4 2011$0.06$0.03ViewN/AView Earnings Details
10/27/2011Q3 2011$0.08$0.06ViewN/AView Earnings Details
7/28/2011Q2 2011$0.09$0.06ViewN/AView Earnings Details
4/28/2011Q1 2011$0.06$0.05ViewN/AView Earnings Details
2/28/2011Q4 2010$0.25ViewN/AView Earnings Details
10/28/2010Q3 2010$0.08$0.09ViewN/AView Earnings Details
7/28/2010Q2 2010$0.06$0.09ViewN/AView Earnings Details
4/29/2010Q1 2010$0.05$0.06ViewN/AView Earnings Details
3/4/2010Q4 2009$0.08ViewN/AView Earnings Details
10/28/2009Q3 2009$0.08ViewN/AView Earnings Details
7/29/2009Q2 2009$0.03$0.06ViewN/AView Earnings Details
4/28/2009Q1 2009($0.17)($0.04)ViewN/AView Earnings Details
3/3/2009Q4 2008$0.03ViewN/AView Earnings Details
10/29/2008Q3 2008($0.02)($0.01)ViewN/AView Earnings Details
7/29/2008Q2 2008($0.04)($0.04)ViewN/AView Earnings Details
4/30/2008Q1 2008($0.07)($0.12)ViewN/AView Earnings Details
3/4/2008Q4 2007($0.03)($0.05)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

LeMaitre Vascular (NASDAQ:LMAT) Earnings Estimates

2018 EPS Consensus Estimate: $0.92
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.19$0.20$0.20
Q2 20182$0.22$0.25$0.24
Q3 20182$0.21$0.24$0.23
Q4 20181$0.26$0.26$0.26
(Earnings estimates data provided by Zacks Investment Research)

Dividends

LeMaitre Vascular (NASDAQ:LMAT) Dividend Information

Most Recent Dividend:12/7/2017
Annual Dividend:$0.22
Dividend Yield:0.62%
Payout Ratio:28.57% (Trailing 12 Months of Earnings)
26.19% (Based on This Year's Estimates)
25.29% (Based on Next Year's Estimates)
Dividend Payments by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/30/2017quarterly$0.060.71%11/21/201711/22/201712/7/2017
7/28/2017quarterly$0.060.64%8/21/20178/23/20179/7/2017
4/28/2017quarterly$0.060.74%5/22/20175/24/20176/8/2017
2/23/2017quarterly$0.061%3/20/20173/22/20174/6/2017
10/27/2016quarterly$0.050.85%11/17/201611/21/201612/5/2016
7/29/2016quarterly$0.051.05%8/18/20168/22/20169/6/2016
5/4/2016quarterly$0.051.12%5/23/20165/25/20166/8/2016
2/25/2016quarterly$0.051.19%3/17/20163/21/20164/4/2016
10/29/2015quarterly$0.041.11%11/18/201511/20/201512/4/2015
7/29/2015quarterly$0.041.25%8/18/20158/20/20159/3/2015
4/29/2015quarterly$0.041.85%5/20/20155/22/20156/5/2015
2/26/2015quarterly$0.042.03%3/18/20153/20/20154/3/2015
10/28/2014quarterly$0.041.93%11/18/201411/20/201412/4/2014
7/31/2014quarterly$0.041.73%8/19/20148/21/20149/4/2014
4/30/2014quarterly$0.041.71%5/20/20145/22/20146/5/2014
2/26/2014quarterly$0.041.75%3/18/20143/20/20144/3/2014
10/31/2013quarterly$0.031.49%11/18/201311/20/201312/4/2013
7/30/2013quarterly$0.031.73%8/19/20138/21/20139/4/2013
5/2/2013quarterly$0.031.98%5/20/20135/22/20136/5/2013
2/27/2013quarterly$0.031.92%3/18/20133/20/20134/3/2013
(Data available from 1/1/2013 forward)

Insider Trades

LeMaitre Vascular (NASDAQ LMAT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 23.70%
Institutional Ownership Percentage: 70.98%
Insider Trades by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Insider Trades by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ LMAT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/6/2017David B RobertsInsiderSell4,123$32.14$132,513.2224,482View SEC Filing  
8/30/2017David B RobertsInsiderSell26,683$36.67$978,465.6148,108View SEC Filing  
8/30/2017George W LemaitreCEOSell15,000$37.13$556,950.003,325,508View SEC Filing  
8/29/2017George W LemaitreCEOSell15,000$36.72$550,800.003,325,508View SEC Filing  
8/28/2017George W LemaitreCEOSell30,000$36.43$1,092,900.003,325,508View SEC Filing  
8/25/2017George W LemaitreChairmanSell40,000$33.89$1,355,600.003,390,508View SEC Filing  
8/24/2017George W LemaitreCEOSell15,000$33.97$509,550.003,390,508View SEC Filing  
8/23/2017George W LemaitreCEOSell5,000$33.91$169,550.003,390,508View SEC Filing  
8/17/2017Lawrence J JasinskiDirectorSell2,030$34.23$69,486.908,333View SEC Filing  
8/11/2017George W LemaitreChairmanSell21,300$32.90$700,770.003,405,508View SEC Filing  
8/10/2017George W LemaitreCEOSell11,300$32.79$370,527.003,405,508View SEC Filing  
8/9/2017George W LemaitreChairmanSell30,000$33.65$1,009,500.003,436,808View SEC Filing  
8/8/2017George W LemaitreCEOSell10,000$34.02$340,200.003,436,808View SEC Filing  
8/7/2017George W LemaitreCEOSell10,000$33.62$336,200.003,436,808View SEC Filing  
8/7/2017Peter R GebauerInsiderSell6,224$33.85$210,682.408,477View SEC Filing  
8/4/2017David B RobertsInsiderSell48,317$33.12$1,600,259.0430,105View SEC Filing  
8/3/2017George W LemaitreChairmanSell58,700$33.97$1,994,039.003,471,808View SEC Filing  
8/3/2017Peter R GebauerInsiderSell22,067$34.28$756,456.764,486View SEC Filing  
8/1/2017Lawrence J JasinskiDirectorSell6,500$34.47$224,055.0012,863View SEC Filing  
6/1/2017Michael T WijasVPSell2,346$31.42$73,711.323,584View SEC Filing  
5/24/2017Trent G KamkeInsiderSell15,780$30.28$477,818.4031,341View SEC Filing  
5/18/2017George W LemaitreChairmanSell21,225$30.11$639,084.753,386,295View SEC Filing  
5/11/2017David B RobertsInsiderSell39,531$30.37$1,200,556.477,414View SEC Filing  
5/10/2017George W LemaitreChairmanSell63,622$30.98$1,971,009.563,450,815View SEC Filing  
5/9/2017George W LemaitreCEOSell34,517$30.67$1,058,636.393,450,815View SEC Filing  
5/8/2017George W LemaitreCEOSell9,102$31.12$283,254.243,450,815View SEC Filing  
5/4/2017David B RobertsInsiderSell44,340$31.14$1,380,747.6046,945View SEC Filing  
5/3/2017George W LemaitreChairmanSell87,342$32.35$2,825,513.703,484,149View SEC Filing  
3/10/2017David B RobertsInsiderSell5,900$22.44$132,396.0046,945View SEC Filing  
3/1/2017George W LemaitreChairmanSell10,000$22.36$223,600.003,451,694View SEC Filing  
2/28/2017George W LemaitreCEOSell3,000$22.27$66,810.003,451,694View SEC Filing  
2/27/2017George W LemaitreCEOSell5,000$22.31$111,550.003,451,694View SEC Filing  
9/16/2016David B RobertsInsiderSell6,452$21.05$135,814.6069,793View SEC Filing  
9/15/2016David B RobertsInsiderSell33,548$20.41$684,714.6879,793View SEC Filing  
9/8/2016George W LemaitreChairmanSell30,000$20.48$614,400.003,395,063View SEC Filing  
9/7/2016David B RobertsInsiderSell20,000$20.07$401,400.00119,793View SEC Filing  
9/2/2016George W LemaitreChairmanSell60,037$18.30$1,098,677.103,443,098View SEC Filing  
8/30/2016Peter R GebauerInsiderSell3,431$18.20$62,444.2031,283View SEC Filing  
8/29/2016Peter R GebauerInsiderSell26,815$17.78$476,770.7031,283View SEC Filing  
8/24/2016David B RobertsInsiderSell10,000$17.35$173,500.00134,793View SEC Filing  
8/24/2016George W LemaitreCEOSell6,800$17.49$118,932.003,491,564View SEC Filing  
8/23/2016George W LemaitreCEOSell19,664$17.43$342,743.523,491,564View SEC Filing  
8/22/2016George W LemaitreCEOSell8,927$17.39$155,240.533,491,564View SEC Filing  
8/19/2016Cornelia W LemaitreDirectorSell5,000$17.15$85,750.00188,858View SEC Filing  
8/18/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00188,858View SEC Filing  
8/15/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00188,858View SEC Filing  
8/15/2016George W LemaitreChairmanSell15,896$17.53$278,656.883,512,839View SEC Filing  
8/9/2016George W LemaitreChairmanSell5,460$17.41$95,058.603,516,387View SEC Filing  
8/9/2016Lawrence J JasinskiDirectorSell7,500$17.60$132,000.0012,863View SEC Filing  
8/5/2016David B RobertsInsiderSell10,000$17.63$176,300.00140,493View SEC Filing  
8/4/2016George W LemaitreChairmanSell4,540$17.65$80,131.003,516,387View SEC Filing  
7/28/2016Peter R GebauerInsiderSell30,000$16.47$494,100.0025,374View SEC Filing  
6/8/2016George W LemaitreCEOSell19,189$15.01$288,026.893,521,849View SEC Filing  
6/7/2016George W LemaitreCEOSell9,100$15.02$136,682.003,521,849View SEC Filing  
6/6/2016George W LemaitreCEOSell900$15.06$13,554.003,521,849View SEC Filing  
6/6/2016Peter R GebauerInsiderSell6,310$14.96$94,397.6053,339View SEC Filing  
6/3/2016Lawrence J JasinskiDirectorSell4,924$14.99$73,810.7612,787View SEC Filing  
6/3/2016Trent G KamkeInsiderSell2,510$15.00$37,650.0015,573View SEC Filing  
5/25/2016Lawrence J JasinskiDirectorSell6,326$15.30$96,787.8015,642View SEC Filing  
5/25/2016Trent G KamkeInsiderSell1,524$15.25$23,241.0018,183View SEC Filing  
5/23/2016Trent G KamkeInsiderSell16,465$15.02$247,304.3012,204View SEC Filing  
5/18/2016George W LemaitreCEOSell2,944$15.23$44,837.123,522,749View SEC Filing  
5/17/2016Trent G KamkeInsiderSell2,400$15.51$37,224.0020,492View SEC Filing  
5/16/2016George W LemaitreCEOSell1,740$15.49$26,952.603,522,749View SEC Filing  
5/13/2016George W LemaitreCEOSell7,451$15.45$115,117.953,522,749View SEC Filing  
5/9/2016George W LemaitreCEOSell110,189$16.17$1,781,756.133,549,133View SEC Filing  
5/6/2016David B RobertsDirectorSell17,064$15.89$271,146.96162,434View SEC Filing  
5/5/2016Trent G KamkeInsiderSell3,327$16.10$53,564.7022,692View SEC Filing  
4/18/2016David B RobertsDirectorSell1,766$16.10$28,432.60147,136View SEC Filing  
4/4/2016David B RobertsDirectorSell17,444$15.99$278,929.56107,605View SEC Filing  
2/25/2016David B RobertsDirectorSell2,690$15.91$42,797.90125,049View SEC Filing  
1/14/2016David B. RobertsDirectorSell12,867$15.85$203,941.95127,739View SEC Filing  
1/11/2016David B RobertsDirectorSell27,490$15.68$431,043.20140,606View SEC Filing  
1/8/2016David B RobertsDirectorSell2,743$15.51$42,543.93168,096View SEC Filing  
12/9/2015Joseph P. Pellegrino, Jr.CFOSell14,348$16.01$229,711.48110,389View SEC Filing  
12/4/2015Peter R. GebauerinsiderSell12,816$15.53$199,032.4870,420View SEC Filing  
12/1/2015Peter R. GebauerinsiderSell37,184$15.73$584,904.3270,420View SEC Filing  
11/25/2015David B. RobertsDirectorSell10,000$15.96$159,600.00170,839View SEC Filing  
11/24/2015Cornelia W LemaitreDirectorSell41,135$15.61$642,117.35182,595View SEC Filing  
11/23/2015George W. LemaitreCEOSell65,052$15.63$1,016,762.763,633,333View SEC Filing  
11/23/2015Joseph P. Pellegrino, Jr.CFOSell45,840$15.57$713,728.80110,389View SEC Filing  
11/23/2015Peter R. GebauerinsiderSell11,971$15.31$183,276.0170,420View SEC Filing  
11/20/2015David B. RobertsDirectorSell10,000$14.73$147,300.00180,839View SEC Filing  
11/20/2015Peter R. GebauerinsiderSell19,900$14.40$286,560.0070,420View SEC Filing  
11/17/2015George W LemaitreCEOSell30,000$14.15$424,500.003,698,385View SEC Filing  
11/16/2015Lawrence J. JasinskiDirectorSell7,500$13.57$101,775.0014,113View SEC Filing  
11/10/2015George W. LemaitreCEOSell57,844$13.80$798,247.203,728,385View SEC Filing  
11/9/2015George W. LemaitreCEOSell7,524$13.70$103,078.803,728,385View SEC Filing  
11/6/2015George W. LemaitreCEOSell39,000$13.83$539,370.003,728,385View SEC Filing  
10/30/2015George W. LemaitreCEOSell16,190$14.55$235,564.503,786,229View SEC Filing  
10/28/2015Peter R. GebauerinsiderSell44,315$13.97$619,080.5570,420View SEC Filing  
9/25/2015Peter R. GebauerinsiderSell5,441$13.91$75,684.3170,420View SEC Filing  
9/18/2015George W. LemaitreCEOSell46,391$14.37$666,638.673,802,419View SEC Filing  
9/17/2015George W. LemaitreCEOSell49,559$13.96$691,843.643,846,869View SEC Filing  
8/31/2015Peter R. GebauerinsiderSell10,465$13.49$141,172.8570,420View SEC Filing  
8/27/2015George W. LemaitreCEOSell28,700$13.66$392,042.003,888,369View SEC Filing  
8/26/2015Peter R. GebauerinsiderSell15,978$13.53$216,182.3470,420View SEC Filing  
8/20/2015David B RobertsDirectorSell12,000$13.58$162,960.00190,839View SEC Filing  
8/19/2015Peter R. GebauerinsiderSell4,022$14.24$57,273.2870,420View SEC Filing  
8/13/2015George W LemaitreCEOSell33,059$13.41$443,321.19View SEC Filing  
5/19/2015Peter R GebauerInsiderSell10,000$10.12$101,200.00View SEC Filing  
5/18/2015George W LemaitreCEOSell20,132$10.01$201,521.32View SEC Filing  
5/11/2015David B RobertsDirectorSell15,000$10.31$154,650.00View SEC Filing  
5/7/2015George W LemaitreCEOSell70,984$9.72$689,964.48View SEC Filing  
5/6/2015David B RobertsDirectorSell11,000$9.27$101,970.00View SEC Filing  
4/29/2015Peter R GebauerInsiderSell15,332$8.99$137,834.68View SEC Filing  
4/16/2015Cornelia W LemaitreDirectorSell17,100$8.55$146,205.00View SEC Filing  
4/14/2015Cornelia W LemaitreDirectorSell6,707$8.42$56,472.94View SEC Filing  
3/31/2015Cornelia W LemaitreDirectorSell819$8.37$6,855.03View SEC Filing  
3/30/2015Cornelia W LemaitreDirectorSell31$8.36$259.16View SEC Filing  
3/25/2015Cornelia W LemaitreDirectorSell3,678$8.33$30,637.74View SEC Filing  
3/24/2015Cornelia W LemaitreDirectorSell3,373$8.33$28,097.09View SEC Filing  
3/23/2015Cornelia W LemaitreDirectorSell26,026$8.21$213,673.46View SEC Filing  
3/18/2015Cornelia W LemaitreDirectorSell5,601$8.03$44,976.03View SEC Filing  
3/10/2015Peter R GebauerInsiderSell10,000$8.15$81,500.00View SEC Filing  
3/9/2015Peter R GebauerInsiderSell7,200$8.15$58,680.00View SEC Filing  
3/6/2015Cornelia W LemaitreDirectorSell6,065$8.20$49,733.00View SEC Filing  
3/3/2015David B RobertsDirectorSell12,000$7.65$91,800.00View SEC Filing  
1/29/2015Peter R GebauerInsiderSell16,919$7.91$133,829.29View SEC Filing  
1/26/2015George W LemaitreCEOSell3,486$7.85$27,365.10View SEC Filing  
1/26/2015Peter R GebauerInsiderSell1,800$7.90$14,220.00View SEC Filing  
1/5/2015George W LemaitreCEOSell18,447$7.74$142,779.78View SEC Filing  
1/2/2015David B RobertsDirectorSell7,000$7.31$51,170.00View SEC Filing  
12/30/2014George W LemaitreCEOSell18,067$7.58$136,947.86View SEC Filing  
12/29/2014George W LemaitreCEOSell5,058$7.59$38,390.22View SEC Filing  
12/26/2014George W LemaitreCEOSell6,693$7.53$50,398.29View SEC Filing  
12/24/2014George W LemaitreCEOSell2,900$7.60$22,040.00View SEC Filing  
12/10/2014George W LemaitreCEOSell1,117$7.40$8,265.80View SEC Filing  
12/9/2014David B RobertsDirectorSell3,000$7.36$22,080.00View SEC Filing  
12/9/2014George W LemaitreCEOSell1,794$7.40$13,275.60View SEC Filing  
11/28/2014George W LemaitreCEOSell42,641$7.40$315,543.40View SEC Filing  
11/25/2014George W LemaitreCEOSell613$7.30$4,474.90View SEC Filing  
11/13/2014Trent G KamkeInsiderSell1,100$7.15$7,865.00View SEC Filing  
11/5/2014George W LemaitreCEOSell28,286$7.07$199,982.02View SEC Filing  
10/31/2014David B RobertsPresidentSell3,500$7.03$24,605.00View SEC Filing  
10/31/2014George W LemaitreCEOSell23,758$7.14$169,632.12View SEC Filing  
9/8/2014George W LemaitreCEOSell29,966$7.10$212,758.60View SEC Filing  
9/4/2014Lawrence J JasinskiDirectorSell3,750$7.14$26,775.00View SEC Filing  
6/25/2014Cornelia W LemaitreDirectorSell4,700$8.32$39,104.00View SEC Filing  
5/7/2014David RobertsPresidentSell3,000$7.95$23,850.00206,710View SEC Filing  
3/7/2014Russell HaysDirectorSell15,000$8.07$121,050.00View SEC Filing  
3/6/2014Cornelia LemaitreDirectorSell6,950$8.15$56,642.50174,581View SEC Filing  
3/6/2014Trent KamkeInsiderSell1,278$8.18$10,454.0416,141View SEC Filing  
3/4/2014Cornelia LemaitreDirectorSell12,845$8.29$106,485.05174,581View SEC Filing  
1/23/2014Cornelia LemaitreDirectorSell3,900$8.24$32,136.00174,581View SEC Filing  
11/1/2013David B RobertsDirectorSell2,000$7.96$15,920.00View SEC Filing  
10/31/2013Cornelia W LemaitreDirectorSell20,000$7.88$157,600.00View SEC Filing  
10/25/2013Cornelia W LemaitreDirectorSell20,000$7.38$147,600.00View SEC Filing  
9/5/2013Joseph P Pellegrino JrCFOSell25,000$6.86$171,500.00View SEC Filing  
9/3/2013David B RobertsDirectorSell6,500$6.90$44,850.00View SEC Filing  
8/14/2013Cornelia W LemaitreDirectorSell7,500$7.00$52,500.00View SEC Filing  
8/12/2013Trent G KamkeInsiderSell2,000$6.90$13,800.00View SEC Filing  
8/8/2013Trent G KamkeInsiderSell2,000$6.83$13,660.00View SEC Filing  
8/2/2013Russell D HaysDirectorSell15,000$6.78$101,700.00View SEC Filing  
7/30/2013David B RobertsDirectorSell12,403$6.85$84,960.55View SEC Filing  
7/29/2013Cornelia W LemaitreDirectorSell2,500$7.00$17,500.00View SEC Filing  
7/26/2013David B RobertsDirectorSell9,100$6.77$61,607.00View SEC Filing  
6/24/2013David B RobertsDirectorSell2,100$6.75$14,175.00View SEC Filing  
6/5/2013Robert V LindenVPSell9,383$6.45$60,520.35View SEC Filing  
5/30/2013Cornelia W LemaitreDirectorSell10,000$6.50$65,000.00View SEC Filing  
11/27/2012Cornelia W LemaitreDirectorSell2,699$6.25$16,868.75View SEC Filing  
8/10/2012George D LemaitreDirectorSell5,862$6.45$37,809.90View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

LeMaitre Vascular (NASDAQ LMAT) News Headlines

Source:
DateHeadline
LeMaitre Vascular Will Announce Fourth Quarter 2017 Earnings Results on February 21, 2018LeMaitre Vascular Will Announce Fourth Quarter 2017 Earnings Results on February 21, 2018
finance.yahoo.com - February 9 at 9:12 AM
LeMaitre Vascular Inc (LMAT) Given Consensus Recommendation of "Hold" by AnalystsLeMaitre Vascular Inc (LMAT) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - February 4 at 1:32 AM
LeMaitre Vascular (LMAT) Raised to Hold at BidaskClubLeMaitre Vascular (LMAT) Raised to Hold at BidaskClub
www.americanbankingnews.com - January 31 at 10:54 PM
LeMaitre Vascular Inc (LMAT) Expected to Post Quarterly Sales of $26.29 MillionLeMaitre Vascular Inc (LMAT) Expected to Post Quarterly Sales of $26.29 Million
www.americanbankingnews.com - January 31 at 9:30 AM
Financial Analysis: Reshape Lifesciences (RSLS) & LeMaitre Vascular (LMAT)Financial Analysis: Reshape Lifesciences (RSLS) & LeMaitre Vascular (LMAT)
www.americanbankingnews.com - January 19 at 5:32 PM
Head-To-Head Survey: Intuitive Surgical (ISRG) & LeMaitre Vascular (LMAT)Head-To-Head Survey: Intuitive Surgical (ISRG) & LeMaitre Vascular (LMAT)
www.americanbankingnews.com - January 17 at 8:20 AM
 Brokerages Expect LeMaitre Vascular Inc (LMAT) to Post $0.19 EPS Brokerages Expect LeMaitre Vascular Inc (LMAT) to Post $0.19 EPS
www.americanbankingnews.com - January 12 at 3:16 AM
LeMaitre Vascular to Present at the Needham Growth Conference on Thursday, January 18, 2018LeMaitre Vascular to Present at the Needham Growth Conference on Thursday, January 18, 2018
finance.yahoo.com - January 11 at 5:06 PM
LeMaitre Vascular Inc (LMAT) Given Consensus Rating of "Hold" by BrokeragesLeMaitre Vascular Inc (LMAT) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - January 10 at 1:44 AM
LeMaitre Vascular (LMAT) Downgraded by BidaskClubLeMaitre Vascular (LMAT) Downgraded by BidaskClub
www.americanbankingnews.com - December 28 at 4:10 PM
LeMaitre Vascular (LMAT) Lifted to Buy at Zacks Investment ResearchLeMaitre Vascular (LMAT) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - December 28 at 7:24 AM
ETFs with exposure to LeMaitre Vascular, Inc. : December 27, 2017ETFs with exposure to LeMaitre Vascular, Inc. : December 27, 2017
finance.yahoo.com - December 27 at 5:51 PM
Zacks: Analysts Expect LeMaitre Vascular Inc (LMAT) Will Post Earnings of $0.19 Per ShareZacks: Analysts Expect LeMaitre Vascular Inc (LMAT) Will Post Earnings of $0.19 Per Share
www.americanbankingnews.com - December 26 at 1:32 PM
$0.19 EPS Expected for LeMaitre Vascular Inc (LMAT) This Quarter$0.19 EPS Expected for LeMaitre Vascular Inc (LMAT) This Quarter
www.americanbankingnews.com - December 26 at 1:32 PM
LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017
finance.yahoo.com - December 26 at 9:23 AM
LeMaitre Vascular, Inc. (LMAT) Receives Average Rating of "Hold" from BrokeragesLeMaitre Vascular, Inc. (LMAT) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - December 16 at 1:52 AM
LeMaitre Vascular, Inc. (LMAT) Expected to Announce Quarterly Sales of $26.29 MillionLeMaitre Vascular, Inc. (LMAT) Expected to Announce Quarterly Sales of $26.29 Million
www.americanbankingnews.com - December 10 at 2:52 AM
BidaskClub Lowers LeMaitre Vascular (LMAT) to SellBidaskClub Lowers LeMaitre Vascular (LMAT) to Sell
www.americanbankingnews.com - December 2 at 12:36 PM
LeMaitre Vascular, Inc. (LMAT) Given Average Rating of "Hold" by BrokeragesLeMaitre Vascular, Inc. (LMAT) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - November 21 at 1:44 AM
$0.19 Earnings Per Share Expected for LeMaitre Vascular, Inc. (LMAT) This Quarter$0.19 Earnings Per Share Expected for LeMaitre Vascular, Inc. (LMAT) This Quarter
www.americanbankingnews.com - November 20 at 11:10 PM
LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for November 21, 2017 - NasdaqLeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for November 21, 2017 - Nasdaq
www.nasdaq.com - November 20 at 9:22 PM
Validea Motley Fool Strategy Daily Upgrade Report - 11/18/2017 - NasdaqValidea Motley Fool Strategy Daily Upgrade Report - 11/18/2017 - Nasdaq
www.nasdaq.com - November 19 at 12:36 AM
LeMaitre Vascular About To Put More Money In Your Pocket (LMAT)LeMaitre Vascular About To Put More Money In Your Pocket (LMAT)
www.thestreet.com - November 18 at 4:26 AM
Should You Buy LeMaitre Vascular Inc (LMAT) Now?Should You Buy LeMaitre Vascular Inc (LMAT) Now?
finance.yahoo.com - November 17 at 8:17 AM
3 Unknown, but Amazing, Dividend Stocks3 Unknown, but Amazing, Dividend Stocks
finance.yahoo.com - November 16 at 10:12 AM
LeMaitre Vascular Reaches Analyst Target PriceLeMaitre Vascular Reaches Analyst Target Price
www.thestreet.com - November 11 at 5:02 PM
David B. Roberts Sells 4,123 Shares of LeMaitre Vascular, Inc. (LMAT) StockDavid B. Roberts Sells 4,123 Shares of LeMaitre Vascular, Inc. (LMAT) Stock
www.americanbankingnews.com - November 7 at 7:10 PM
Analyzing LeMaitre Vascular (LMAT) and Its PeersAnalyzing LeMaitre Vascular (LMAT) and Its Peers
www.americanbankingnews.com - November 7 at 5:34 AM
LeMaitre Vascular, Inc. Expected to Post Q1 2018 Earnings of $0.20 Per Share (LMAT)LeMaitre Vascular, Inc. Expected to Post Q1 2018 Earnings of $0.20 Per Share (LMAT)
www.americanbankingnews.com - November 2 at 1:02 PM
LeMaitre Vascular to Present at Upcoming November and December Investor ConferencesLeMaitre Vascular to Present at Upcoming November and December Investor Conferences
finance.yahoo.com - November 2 at 5:43 AM
LeMaitre Vascular, Inc. (LMAT) Cut to Hold at Zacks Investment ResearchLeMaitre Vascular, Inc. (LMAT) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - November 2 at 12:56 AM
LeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : October 31, 2017LeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : October 31, 2017
finance.yahoo.com - November 1 at 5:27 AM
LeMaitre Vascular (LMAT) & Its Peers Head-To-Head SurveyLeMaitre Vascular (LMAT) & Its Peers Head-To-Head Survey
www.americanbankingnews.com - October 31 at 3:20 AM
LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : October 30, 2017LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : October 30, 2017
finance.yahoo.com - October 31 at 1:12 AM
ETFs with exposure to LeMaitre Vascular, Inc. : October 30, 2017ETFs with exposure to LeMaitre Vascular, Inc. : October 30, 2017
finance.yahoo.com - October 31 at 1:12 AM
LeMaitre Vascular, Inc. (LMAT) Plans Quarterly Dividend of $0.06LeMaitre Vascular, Inc. (LMAT) Plans Quarterly Dividend of $0.06
www.americanbankingnews.com - October 30 at 6:24 PM
LeMaitre Vascular, Inc. (LMAT) to Post FY2017 Earnings of $0.84 Per Share, Barrington Research ForecastsLeMaitre Vascular, Inc. (LMAT) to Post FY2017 Earnings of $0.84 Per Share, Barrington Research Forecasts
www.americanbankingnews.com - October 30 at 3:24 AM
LeMaitre Vascular Is Now Oversold (LMAT)LeMaitre Vascular Is Now Oversold (LMAT)
www.thestreet.com - October 29 at 7:20 PM
YieldBoost LeMaitre Vascular To 6% Using OptionsYieldBoost LeMaitre Vascular To 6% Using Options
www.thestreet.com - October 28 at 7:46 AM
Edited Transcript of LMAT earnings conference call or presentation 26-Oct-17 9:00pm GMTEdited Transcript of LMAT earnings conference call or presentation 26-Oct-17 9:00pm GMT
finance.yahoo.com - October 28 at 7:46 AM
LeMaitre Vascular, Inc. (LMAT) PT Lowered to $29.00LeMaitre Vascular, Inc. (LMAT) PT Lowered to $29.00
www.americanbankingnews.com - October 27 at 6:20 PM
LeMaitre Vascular, Inc. (LMAT) Receives Average Recommendation of "Hold" from AnalystsLeMaitre Vascular, Inc. (LMAT) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - October 27 at 1:30 AM
LeMaitre beats 3Q profit forecastsLeMaitre beats 3Q profit forecasts
finance.yahoo.com - October 26 at 11:20 PM
LeMaitre Vascular, Inc. (LMAT) Issues  Earnings Results, Beats Estimates By $0.05 EPSLeMaitre Vascular, Inc. (LMAT) Issues Earnings Results, Beats Estimates By $0.05 EPS
www.americanbankingnews.com - October 26 at 10:56 PM
LeMaitre Vascular, Inc. (LMAT) Issues Q4 Earnings GuidanceLeMaitre Vascular, Inc. (LMAT) Issues Q4 Earnings Guidance
www.americanbankingnews.com - October 26 at 6:03 PM
LeMaitre Vascular, Inc. to Host Earnings CallLeMaitre Vascular, Inc. to Host Earnings Call
finance.yahoo.com - October 26 at 5:54 PM
LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%)LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%)
finance.yahoo.com - October 26 at 5:54 PM
Critical Analysis: EDAP TMS (EDAP) and LeMaitre Vascular (LMAT)Critical Analysis: EDAP TMS (EDAP) and LeMaitre Vascular (LMAT)
www.americanbankingnews.com - October 24 at 4:38 PM
LeMaitre Vascular (LMAT) & Its Competitors Head to Head AnalysisLeMaitre Vascular (LMAT) & Its Competitors Head to Head Analysis
www.americanbankingnews.com - October 21 at 8:15 AM
Financial Analysis: LeMaitre Vascular (LMAT) vs. Its RivalsFinancial Analysis: LeMaitre Vascular (LMAT) vs. Its Rivals
www.americanbankingnews.com - October 18 at 6:36 AM

SEC Filings

LeMaitre Vascular (NASDAQ:LMAT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

LeMaitre Vascular (NASDAQ:LMAT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

LeMaitre Vascular (NASDAQ LMAT) Stock Chart for Sunday, February, 18, 2018

Loading chart…

This page was last updated on 2/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.